ADVAIR HFA

LOE Approaching

fluticasone propionate and salmeterol xinafoate

NDAINHALATIONAEROSOL, METERED
Approved
Jun 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

salmeterol. The mechanisms of action described below for the individual components apply to ADVAIR HFA. These drugs represent 2 different classes of medications (a synthetic corticosteroid and a LABA) that have different effects on clinical, physiologic, and inflammatory indices of asthma.…

Clinical Trials (3)

NCT06040268Phase 1/2Recruiting

Advair HFA in Healthy and HAPE Predisposed Subjects

Started Dec 2023
60 enrolled
Altitude Edema
NCT00633217Phase 4Completed

Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)

Started Mar 2008
247 enrolled
Pulmonary Disease, Chronic Obstructive
NCT00400608Phase 4Completed

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS

Started Oct 2006
28 enrolled
Asthma